# Repaglinide

NDC: 57237-159
Generic name: Repaglinide
Labeler / Manufacturer: Rising Pharma Holdings, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20140122

FDA application: ANDA203820

## Active ingredients

- REPAGLINIDE: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"57237-159"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=57237-159
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d7673e22-0dbb-4395-ad60-943d249203a1